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PLATELET-activating factor (PAF) inhibits single in-
wardly rectifying K
/ channels in guinea-pig ventricular
cells. There is currently little information as to the
mechanism by which these channels are modulated. The
effect ofPAF on quasi steady-state inwardly rectifying K
/
currents (presumably of the Iil type) of auricular, atrial
and ventricular cardiomyocytes from guinea-pig were
studied. Applying the patch-clamp technique in the
whole-cell configuration, PAF (10 nM) reduced the K
/
currents in all three cell types. The inhibitory effect ofPAF
occurred within seconds and was reversible upon
wash-out. It was almost completely abolished by the PAF
receptor antagonist BN 50730. Intracellular infusion of
atrial cells with guanine 5’-(j-thio)diphosphate (GDPS)
or pretreatment of cells with pertussis toxin abolished the
PAF dependent reduction of the currents. Neither
extracellularly applied isoproterenol nor intracellularly
applied adenosine 3’,5’-cyclic monophosphate (cyclic
AMP) attenuated the PAF effect. In multicellular
preparations of auricles, PAF (10 nM) induced arrhyth-
mias. The arrhythmogenic activity was also reduced by
BN 50730. The data indicate that activated PAF receptors
inhibit inwardly rectifying K
/ currents via a pertussis
toxin sensitive G-protein without involvement of a cyclic
AMP-dependent step. Since IIl is a major component in
stabilizing the resting membrane potential, the observed
inhibition of this type of channel could play an important
role in PAF dependent arrhythmogenesis in guinea-pig
heart.
Key words: Arrhythmias, G-protein, Inwardly rectifying K+
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Introduction
Platelet-activating factor (PAF, 1-O-alkyl-2-
(R)acetyl-sn-glyceryl-3-phosphocholine) is released
from endothelial cells and several types of blood
ceils in acute allergic and inflammatory reactions
".(for a review see Snyderl). In the whole heart PAF
is released under ischaemic conditions.
2 When
administered to isolated perfused guinea-pig hearts,
PAF reduced the coronary blood flow and exerted
negative inotropism.
3-5 The negative inotropic
effect was also seen in isolated papillary muscles6
and auricular preparations of guinea-pig heart.7
PAF has also been reported to induce arrhyth-
3 mias in isolated Langendorff hearts and in isolated
guinea-pig papillary muscles.
9 In guinea-pig ven-
tricular cardiomyocytes PAF has been shown to
inhibit single inwardly rectifying K+ channels.1
Since the current through this channel type is
assumed to stabilize the resting membrane potential
and excitability of cardiac cells, the inhibition of
inwardly rectifying K+ channels induced by PAF
has been suggested to contribute to the genesis of
(C) 1994 Rapid Communications of Oxford Ltd
arrhythmias. The recent recognition of the
inhibitory effect of PAF on ventricular inwardly
rectifying K+ channels prompted us to examine the
inhibitory effects of PAF on these currents in
cardiomyocytes from various regions of the
guinea-pig heart and the possible involvement of
G-proteins and cyclic AMP in this process.
Materials and Methods
Single cardiomyocytes: Single cardiomyocytes were
prepared by the method previously described by
Trube and Hescheler. In brief, adult guinea-pigs
of either sex (200-250 g) were anaesthetized with
ether. The chest was opened, the heart was rapidly
removed and washed twice in Tyrode’s solution. 1’12
Retrograde perfusion through the aorta was
performed at 37C using a Langendorff apparatus.
The elapsed time from excision of the heart to
cannulation and perfusion was less than 1.5 min.
The heart was perfused with nominally calcium-free
Tyrode’s solution ([gag+], 10-20/,M) at a rate of
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12 ml/min for 5 min. After this period, collagenase
(Yakult-Honsha), at a concentration of 0.04%, was
added to the calcium-free Tyrode’s solution and was
recirculated through the heart for 10-20 min. The
heart was then removed from the cannula, the atria
were separated from the ventricles by cutting, and
the auricles were dissected from the atria. Then the
auricles, the atria (atria without auricles) and the
ventricles were placed into separate flasks and cut
into small pieces. Incubation in the collagenase-
containing solution proceeded for an additional
5-10min, during which gentle agitation was
provided using a 10 ml pipette. The resulting cell
suspensions were filtered through a nylon mesh and
centrifuged. The cell pellets were resuspended in
’KB ’1, recentrifuged and washed twice in this
solution.
Cells were kept at 6-8C for 1 to 2 days in ’KB’
or modified Tyrode’s solution (see below) contain-
ing 50% Dulbecco’s modified Eagle’s medium
supplemented with 10% (v/v) horse serum, 4mM
glutamine, 1% (w/v) non-essential amino acids and,
if indicated, treated with pertussis toxin (50 ng/ml)
for 20-24h prior to the experiments. For
electrophysiological experiments, cells were trans-
ferred into a chamber (0.2 ml) and continuously
superfused with a modified Tyrode’s solution
containing (in mM)" NaC1 140, CaC12 1.8, MgC12 1,
KC1 5.4, glucose 10, Na-HEPES 10 (pH 7.4, 37C)
at a rate of 5 ml/min (for some details see Gollasch
et al.13). Whole-cell membrane currents were
measured according to the method of Hamill et a1.14
If not stated otherwise, recording of currents was
usually started 5min after disruption of the
membrane patch for intracellular dialysis with the
pipette solution. Patch electrodes had an average
resistance of 1-2 Mr/ when filled with (in mM)"
K-aspartate 80, KC1 50, MgCI2 1, Mg-ATP 3,
EGTA 10, K-HEPES 10 (pH 7.4). For intracellular
infusion of cardiomyocytes with guanine 5’-(3-
thio)diphosphate (GDP/S), the pipette solution
contained additionally 100 #M GDPflS.13’s Quasi
steady-state current-voltage relations of inwardly
rectifying K+ currents were measured using linear
voltage-ramp pulses
16 depolarizing the membrane
within 3s from--100mV to -40mV (rate of
pulses 0.2 Hz). The method of measurement of
steady-state currents through inwardly rectifying
K+ channels is subject to small errors which might
arise as a result of the existence of overlapping
time dependent currents.
For the electrophysiological experiments, only
quiescent relaxed auricular, atrial and ventricular
cells with clear striations were used. Significant
alterations in the slope conductances of the
inwardly rectifying K+ currents and in the
-adrenergic stimulation of Ca2+ currents during
storage of the cells, were not observed.
Isolated auricular muscle" Auricular muscles dissected
from left atria were prepared from guinea-pigs
anaesthetized with ether as described previously.
7
The muscles were superfused with gassed (95% O2
and 5% CO2) Tyrode’s solution composed of (in
mM)" NaC1 136.9, KC1 2.7, NaHCO3 22.4, CaCI.
1.8, MgCI2 1, NaHePO4 0.5, glucose 5.6 (pH 7.3-7.4
at 37C). The flow rate was 7 ml/min. The muscles
were paced at 0.5 Hz by square wave pulses
(duration 1 ms; voltage was adjusted to 1.5-fold
about threshold) and isometric contractions were
measured using a force transducer type 316 with
RCA-5734 (Hugo Sachs Elektronik, Freiburg,
Germany), as described previously.
7 Data were
analysed off-line using a program written by
D. Lewinsohn.
Materials: PAF (C6) was obtained from Serva
(Heidelberg, Germany). Collagenase and guanine
5’-(//-thio)diphosphate (GDPflS) were purchased
from Yakult-Honsha (Tokyo, Japan) and Cal-
biochem (Bad Soden, Germany), respectively. BN
50730 and pertussis toxin were kindly provided by
Dr P. Braquet (IHB Research Labs, Le Plessis,
France) and Dr M. Yajima (Kyoto, Japan),
respectively. Glutamine and non-essential amino
acids were purchased from Biochrom (Berlin,
Germany); horse serum was from GIBCO (Paisley,
UK).
PAF was dissolved in saline containing 0.25%
bovine serum albumin. BN 50730 (P. Bracluet and
J. Escanu) was dissolved in a stock solution o 1"2
dimethylsuloxide (DMSO) 100% ethanol at
4 mg/ml. Immediately beore application, an equal
volume o 0.2 N HC1 was added and this was
diluted in 0.9% NaC1. The nal concentrations o
DMSO and ethanol had no etect on inwardly
rectifying K+ currents and on contractions.
Statistics" All values are mean-+-S.E.M.; n repre-
sents the number of cells examined. Differences
between means were tested for statistical signifi-
cance by the Wilcoxon rank sum test or Mann-
Whitney-Wilcoxon on test. p < 0.05 was
considered significant.
Results
Effect of PAF on inward rectifying K+ currents"
Inwardly rectifying K+ currents were studied in
auricular, atrial and ventricular cardiomyocytes
from guinea-pigs (Fig. 1). In 5.4 mM extracellular
K +, currents reversed at 71 _+ 3 mV (n 5),
-76_+3mV (n=8) and -78___3mV (n=5),
respectively. As required for a current mainly
carried by K+, the reversal potential (Erev) shifted
when cells were exposed to different levels of
external K +. Ere was found to be -63_ 4 mV
(n= 4) and -51 4mV in atrial cells and
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FIG. 1. Effect of PAF on inwardly rectifying K conductance in auricular
(Panel A), atrial (Panel B) and ventricular (Panel C) cells. Cells were
held at -80 mV, and linear voltage-ramp pulses of 20 mV/s were applied.
Con, control current-voltage relationship; PAF, current-voltage relation-
ship in the presence of PAF; W, current-voltage relationship after
washout of PAF. Dashed lines represent zero currents.
inwardly rectifying K+ currents represent the most
likely currents through IK1 channels, since the
electrophysiological and pharmacological prop-
erties correspond to the I1 channel type extensively
studied in atrium and ventricle.1’9
PAF (10 nM) reduced inwardly rectifying cur-
rents (Figs 1 and 3); the slope conductance
measured at the zero current potential declined
from -23___2nS to -18___2nS (n=5) in
auricular and from -64+4nS to -35+3nS
(n--6) in atrial cells. Between --95 and -90 mV
the slope conductance was reduced from -24 _-q- 6
nS to -19 + 3nS in auricular cells and from
-77+8nS to -48+9nS in atrial cells. In
ventricular cells the slope conductance measured at
the zero current potential was decreased by PAF
from --90 --F_ 6 nS to --58 --F_ 9 nS; between -95
and 90 mV it was reduced from -272 19 nS
to -237 +_ 13 nS (n 5). Ere was not significantly
reduced in atrial, auricular and ventricular cells
(5-F7mV (n=6), 3_--t-6mV (n=5) and 3_--F4
mV (n= 5) depolarization, respectively). The
inhibitory effect of PAF on I:1 occurred within
seconds and was fully reversible after removal from
the bath (Fig. 4). On further applications (up to
four times during the superfusion period of
approximately 15min), the inhibition was of
reproducible amplitude (not shown).
In order to demonstrate the involvement of
PAF receptors in the inhibition of the currents,
the specific PAF receptor antagonist BN 50730
was used.
20-22 Whereas external application of BN
50730 (1/M) did not affect control currents of
atrial cells, the inhibitory effect of PAF (10 nM)
on the current was almost completely abolished in
the presence of BN 50730 (1 #M) (Fig. 4). In five
cells the mean attenuation of inwardly rectifying
currents by PAF (10 nM) plus BN 50730 (1
was --3 _--t- 3%. As demonstrated in Fig. 4 (points
d-f in panel B), the blockage of the PAF (10 nM)
effect by BN 50730 (1 #M) occurred quickly. To
block the effect of 1 #M PAF, BN 50730 had to
be administered at a concentration of 10/M.
-66___5mV(n=4) and -53_6mV (n=3) in
ventricular cells using 11 mM and 22 mM external
K+, respectively. At 2 mM K+ outside, the current
reversed at a potential below -100 mV. The
current was further characterized by its inward
rectification; the slope conductance was large below
the reversal and declined at more positive
potentials. Currents could be blocked by Ba+
(10 raM) or Cs + (5 raM) (see Fig. 2 for auricular
ceils; not shown for atrial and ventricular cells but
see Bechem et al.8). Extracellular application of
gag+ channel blockers Cd
2+ (1 mM) or ___)-isradi-
pine (1/.tM) did not modify the currents. The
Involvement of GTP-binding proteins" The PAF receptor
interacts with its effectors through GTP-binding
(G) proteins. Therefore, we tested whether the
PAF effect on the K+ current is sensitive to
GDPflS, (100M), a GDP analogue which
stabilizes all G-proteins in their inactive form.
Intracellular infusion of GDPflS for 2-3 min via the
patch-pipette only marginally affected the PAF
dependent inhibition of the current (Fig. 5). A
significant reduction of the PAF effect was seen
after longer periods of cell dialysis with GDP/gS.
After 5-7 min cell dialysis PAF induced a current
inhibition of 11 _--F 9% (n 5); after 10-15 min the
current was inhibited by 10 8% (n-- 3, Fig. 5).
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FIG. 2. Effect of Cd2+, Ba2+ and Cs on inwardly rectifying K currents in cells isolated from guinea-pig auricular muscle. Cells were held at -80
mV, and linear voltage-ramp pulses of 20 mV/s were applied. Con, control current-voltage relationships; Cd2+ (Panel A), Ba2+ (Panel B) and Cs
(Panel C), current-voltage relationships in the presence of mM Cd2+, 10mM Ba2+ and 5mM Cs +, respectively; W, current-voltage
relationships after removal of PAF from the bath. Dashed lines represent zero currents.
This is in line with the calculated diffusion velocity
of GDP/YS (mol. wt 477) through the pipette
opening,
is
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FIG. 3. Inhibition of inwardly rectifying K currents by PAF in auricular,
atrial and ventricular guinea-pig cardiomyocytes. The figure shows the
percentage of inhibition of the slope conductance of inwardly rectifying
K currents by PAF (10 nM) in untreated cells (open symbols, x and
+) and in cells treated with pertussis toxin (filled symbols, 50 ng/ml) at
different times after enzymatic isolation of cardiomyocytes. The slope
conductance was determined at zero current potential. Identical forms of
symbols indicate that the cells were obtained from the same hearts.
Cardiomyocytes obtained from hearts x and + were intracellularly
infused with 100 #M cAMP (intracellular dialysis, 5-10 min).
confirmed by pretreatment of cells with pertussis
toxin (PT). This exotoxin from Bordetella pertussis is
known to add ADP-ribosyl to the -subunits of the
Gi- as well as Go- like G-proteins, thus preventing
the coupling of hormone activated receptors to
G-proteins.
23 In atrial cells pretreated with PT, PAF
(10 nM) failed to inhibit the K+ current (Figs 3
and 5); the mean modulation of the current was
--4 _
4% (n 5).
PT sensitive G-proteins are known to couple
receptors with the effector enzyme adenylyl
A nA nA
; ; ; -1 0 -80 -60 mV -100 0 0 mV
B
Time (min)
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FIG. 4: Effect of BN 50370 on the PAF dependent inhibition of inwardly
rectifying K current. The atrial cell was held at -80 mV, and linear
voltage-ramp pulses of 20 mV/s were applied. Panel A: superimposed
current-voltage relationships (a-f) defined in the time course of the
experiment shown in Panel B. The presence of PAF (10 nM) and BN
50730 (1 #M) in the bath is indicated by horizontal bars. gK1, slope
conductance of the inwardly rectifying K current determined at
-80 mV. Dashed lines represent zero currents. After wash-out of BN
50370 and PAF, the subsequent addition of PAF (10 nM) to the bath
caused an inhibition of gK1 comparable to those of the previous PAF
applications (not shown).
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FIG. 5. Effects of GDP/S, pertussis toxin and cAMP on the PAF
dependent inhibition of inwardly rectifying K current. Atrial cells were
held at -80mV, and linear voltage-ramp pulses of 20mV/s were
applied. Panel A: superimposed current-voltage relationships (a-f)
defined in the time course of the experiment shown in Panel B. Recording
of currents was started 30 after disruption of the membrane for
intracellular dialysis with pipette solution containing 100 #M GD P/S. The
presence of PAF (10 nM) in the bath is indicated by horizontal bars. gK1,
slope conductance of the inwardly rectifying K current determined at
-80 mV. Panel C: shows the current-voltage relationships recorded from
cells pretreated with pertussis toxin (PT, 50 ng/ml, left part of the panel)
and intracellularly dialysed with pipette solution containing 100#M
cAMP for 8 rain prior to the experiment (right part of the panel). Con,
control current-voltage relationships before application of PAF; PAF,
current-voltage relationships in the presence of PAF (10nM); W,
current-voltage relationships after removal of PAF from the bath. Dashed
lines represent zero currents.
cyclase.
24 In endothelial cells and platelets it has
been demonstrated that PAF receptors inhibit the
adenylyl cyclase.2s’26 To test whether such a
mechanism is involved in the inhibition of inwardly
rectifying K+ currents, a possible involvement of
adenosine 3’,5’-cyclic monophosphate (cyclic AMP)
in the regulation of the current was examined. It
was found that direct intracellular application of
cyclic AMP (100/.tM in the pipette solution) had no
effect on the K+ current during 5-10 min infusion
and did not prevent the PAF dependent reduction
of the current in atrial cells (n 4, see Figs 3 and 5).
Arrhythmogenic activity of PAF" In isolated left
guinea-pig auricle muscles, contractile responses
were observed for about 10 min prior to each
experiment. During this period, no extrasystoles
were seen; the interval between electrically
stimulated beats remained stable at 2 s; no extra
beats were observed.
PAF (10 nM, 10--15 min superfusion time)
induced rhythm disturbances in nine out of 15
muscles studied. The rhythm disturbances induced
by PAF occurred without detectable delay after
PAF application and were equally distributed
during the whole superfusion period of PAF. The
interval from beat-to-beat in the muscles with PAF
induced arrhythmic activity was reduced to
0.6 0.4 s; 86.4 -+- 37.6 extra beats per min were
detected during the PAF application (n 9, 10 min
of PAF superfusion). The amplitude of contraction
was on average reduced by PAF to 61 _-+-7% of
control values (see also Gollasch et al.V).
BN 50730 (1/.tM) inhibited the PAF induced
rhythm disturbances. In the nine muscles with PAF
induced arrhythmic activity the PAF receptor
antagonist increased the interval from beat-to-beat
to 1.9 -+- 0.2 s; 5.1 -+- 1.8 extra beats per min were
observed during superfusion of the drugs. When
BN 50730 (1-10/.tM) was applied 10 min prior to
application of PAF (10 nM), no arrhythmias were
detected within 20 min superfusion of the drugs
(n 4, see also Koltai et a/.22). The PAF-reduced
amplitude of contraction was restored by BN 50730
to 90 + 12% of control values.
Discussion
Evidence is presented that PAF inhibits inwardly
rectifying K+ currents (presumably of the I:l-type)
in cardiomyocytes from various regions of guinea-
pig heart. Since the effect of PAF occurred at low
concentrations of PAF (nanomolar range) and was
fully antagonized by BN 50730, presumably it is
mediated by specific cardiac receptors for PAF.1
As shown in other cellular systems the PAF
receptor(s) couples to its effector via G-proteins. It
was found that the inhibitory effect of PAF on the
inwardly rectifying K+ current was suppressed by
GDP/S as well as pertussis toxin (PT). These
results suggest the involvement of a PT sensitive
G-protein in the receptor-induced reduction of the
currents. In heart, G-protein dependent regulation
of various types ofK+ channels has been described.
PT sensitive G:-proteins (Oil Oi2 and Oi3 are
involved in the muscarinic acetylcholine receptor
dependent activation of the KACh current in atrial
ceils. The ATP sensitive K+ channel (KA:rV) is
directly activated by PT-sensitive Gi3 proteins;
pacemaker K+ channels (If) are activated by
/-adrenoceptors via Gs-proteins and inhibited by
muscarinic agonists via PT sensitive Go(i) proteins
(for review see Brown and Birnbaumer23).
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The data from Wahler et al.1 support the view
that the PAF-induced inhibition of inwardly rectify-
ing K+ currents is mediated by intracellular messen-
gers. These authors observed an inhibition of single
inwardly rectifying K+ channels (i:1) in cell-
attached patches following application of 1 nM PAF
to the bath. Under these conditions the decrease of
channel activity occurred with a delay of 7-10 min.
In contrast, whole-cell inwardly rectifying K+ cur-
rents were reduced within 10-20 s by PAF at 10 nM
(present data); 1 nM PAF decreased the current
after a delay of 0.5-1.5 min (M.G., unpublished).
The faster effect ofPAF on whole-cell currents may
be explained by usage of the whole-cell clamp
configuration which favours the ready diffusion of
intracellular messengers from the PAF receptor to
the channel protein.
Possible candidate messengers are products gen-
erated by phospholipase A2 (PLA2) which is acti-
vated via PAF receptors in various cell types.
Whereas the hormonal activation of phospholipase
C in most cell types, including cardiomyocytes, is
insensitive to PT, activation of PLA2, e.g. by
l-adrenoceptor stimulation, may be sensitive to the
toxin.27 The stimulation of 0q-adrenoceptors causes
a PT sensitive decrease of inwardly rectifying K+
current (I:1) in canine Purkinje fibres.
28
Nakajima et al.
29 reported a PT sensitive mechan-
ism for activation of guinea-pig atrial Kach channels
by PAF at micromolar concentrations probably
being mediated by arachidonic acid metabolites
(under GTP conditions). An activation of mus-
carinic K+ current by PAF (>0.2/M) was also
observed in bullfrog atrial myocytes.
3 The authors,
however, found that inhibition of 5- and 12-1ip-
oxygenases by eicosatetranoic acid did not prevent
the PAF-mediated increase in muscarinic K +
current. Therefore, Ramos-Franco et al.3 suggested
that the mechanism of PAF action on bullfrog
muscarinic K+ current is analogous to acetylcholine
in that PAF binds to its (low-affinity) receptor,
which is coupled to a G-protein (possibly
which in turn activates KAch channels.
It has been suggested that subtypes of PAF
receptors exist. Both high-affinity (Kd in the lower
nM range) and low-affinity (Kd, 10-500 nM or
more) receptors for PAF have been described. The
involvement of low-affinity binding sites in PAF
dependent activation of muscarinic K+ current was
suggested by the high PAF concentrations (micro-
molar range) used in the studies of Nakajima et al.29
and Ramos-Franco et al.
3 PAF at concentrations
below 0.2 #M did not increase KACh .29’30
The presence of PAF receptors with high-affinity
binding sites in cardiomyocytes mediating the in-
hibition of inwardly rectifying K+ currents can be
suggested by the PAF concentrations (nanomolar
range) used in this and in the study of Wahler et
al. High concentrations of PAF (micromolar
range) also induced an inhibition of the current.
Therefore, one might suggest that the inhibition of
cardiac inwardly rectifying K+ (i:) currents is
mediated by a PAF receptor subtype different from
that stimulating atrial KAch channels.
The initiation of cardiac excitation in working
myocardium depends on the threshold to generate
an action potential, which by itself is determined by
I:.
3 A large I: implies that the resting potential
is ’stabilized’, i.e. stronger depolarizing currents are
necessary to trigger an action potential.
3 Data
obtained with low concentrations of Ba2+ suggest
that the inhibition of inwardly rectifying K+
channels is causally related to arrhythmogenesis in
ventricular fibres.32 By analogy, the PAF dependent
inhibition of inwardly rectifying K+ currents may
contribute to the genesis of observed arrhythmias
and automaticity in multicellular cardiac prepara-
tions. Indeed, PAF induces rhythm disturbances in
auricular multicellular preparations and also inhibits
inwardly rectifying K+ currents in cardiomyocytes
isolated from supraventricular regions of the heart
at the same range of concentration.
With regard to the previous literature, the
observed inhibition of inwardly rectifying K+ cur-
rents is certainly not the only effect of PAF on
cardiomyocytes. At low concentrations (nanomolar
range) PAF augments Ca2+ currents in multicellular
guinea-pig preparations. 6’7’33 At high concentrations
(micromolar range) PAF has been demonstrated to
decrease intracellular Na+ activity,
34 to reduce Ca2+
currents and to stimulate an outward current pre-
sumably through delayed outward K+ channels in
frog atrial trabeculae. Although these mechanisms
might also play a role in PAF induced arrhythmo-
genesis, they would act synergistically to cause
arrhythmias in multicellular preparations.
Numerous questions about the processes in-
volved in PAF induced arrhythmogenesis in heart
muscle still remain (modulation of other ion
transport systems, influence of endothelium etc.).
Nevertheless, it is felt confidently that the
hypotheses on the involvement of PAF inhibited
Ii( in arrhythmogenesis will be useful to guide
this work.
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